INTERSTITIAL LUNG DISEASE AND HEART MANIFESTATIONS ASSOCIATED WITH SYSTEMIC SCLEROSIS DURING RITUXIMAB TREATMENT

被引：0
|
作者：
Garzanova, Liudmila
Ananyeva, Lidia
Koneva, Olga A.
Ovsyannikova, Olga
Starovoytova, Mayya
Desinova, Oxana
Shayakhmetova, Rushana
Khelkovskaya-Sergeeva, Anna
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.2037
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：3110A / 3111A
页数：2
相关论文
共 50 条
  • [31] THE PARAMETERS RELATED TO DECLINE OF LUNG FUNCTION ON RITUXIMAB THERAPY IN PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS
    Ananyeva, L. P.
    Garzanova, L.
    Glukhova, S.
    Desinova, O.
    Koneva, O.
    Starovoytova, M.
    Shayakhmetova, R.
    Ovsyannikova, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 727 - 727
  • [32] Treatment of systemic sclerosis-associated interstitial lung disease: a work in progress
    Oldham, Justin M.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (01): : 5 - 7
  • [33] Nintedanib in the treatment of interstitial lung disease associated with systemic sclerosis: A justified hope?
    Hachulla, E.
    REVUE DE MEDECINE INTERNE, 2019, 40 (12): : 775 - 777
  • [34] Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
    Volkmann, Elizabeth R.
    Wilhalme, Holly
    Tashkin, Donald P.
    Kim, Grace Hyun J.
    Goldin, Jonathan
    Haussmann, Alana
    Kuwana, Masataka
    Roth, Michael D.
    Assassi, Shervin
    ARTHRITIS CARE & RESEARCH, 2025,
  • [35] Treatment Response Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease
    Volkmann, Elizabeth
    Wilhalme, Holly
    Tashkin, Donald
    Kim, Grace
    Goldin, Jonathan
    Haussmann, Alana
    Kuwana, Masataka
    Roth, Michael
    Assassi, Shervin
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 3448 - 3449
  • [36] EFFICIENCY OF RITUXIMAB THERAPY IN PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS DEPENDING ON THE FORM AND DURATION OF THE DISEASE
    Garzanova, Liudmila
    Ananyeva, Lidia
    Koneva, Olga A.
    Ovsyannikova, Olga
    Desinova, Oxana
    Starovoytova, Mayya
    Shayakhmetova, Rushana
    Khelkovskaya-Sergeeva, Anna
    CHEST, 2023, 164 (04) : 3118A - 3119A
  • [37] FREQUENCY OF INFECTIONS AND DECREASE OF IGG IN INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS ON RITUXIMAB AND IMMUNOSUPPRESSANT THERAPY
    Garzanova, Liudmila
    Ananatva, Lidia
    Koneva, Olga
    Ovsyannikova, Olga
    Desinova, Oxana
    Starovoytova, Mayya
    Shayakhmetova, Rushana
    CHEST, 2022, 162 (04) : 1259A - 1259A
  • [38] PROGRESSIVE INTERSTITIAL LUNG DISEASE IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
    Cuomo, G.
    Di Vico, C.
    Perretta, D.
    Iandoli, C.
    Ciaburri, R.
    Adamo, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1657 - 1658
  • [39] STUDY OF RITUXIMAB EFFICACY PREDICTORS IN PATIENTS WITH SYSTEMIC SCLEROSIS WITH INTERSTITIAL LUNG DISEASE
    Koneva, Olga
    Ananyeva, Lidia
    Garzanova, Liudmila
    Desinova, Oxana
    Ovsynnikova, Olga
    Starovoytova, Mayya
    CHEST, 2021, 160 (04) : 2148A - 2148A
  • [40] Successful treatment with rituximab in a Japanese patient with systemic sclerosis-associated interstitial lung disease resistant to oral steroid and cyclophosphamide
    Numajiri, Hiroko
    Yoshizaki, Ayumi
    Ebata, Satoshi
    Fukasawa, Takemichi
    Yamashita, Takashi
    Takahashi, Takehiro
    Taniguchi, Takashi
    Asano, Yoshihide
    Sato, Shinichi
    JOURNAL OF DERMATOLOGY, 2018, 45 (06): : E140 - E141
12345